Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration

[1]  O. Rønnekleiv,et al.  17-β Estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain , 2005, Neuroscience.

[2]  Maria Speranza Desole,et al.  Hormones Are Key Actors in Gene X Environment Interactions Programming the Vulnerability to Parkinson's Disease: Glia as a Common Final Pathway , 2005, Annals of the New York Academy of Sciences.

[3]  B. Marchetti,et al.  To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? , 2005, Trends in pharmacological sciences.

[4]  B. Marchetti,et al.  Signaling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: Role of extracellular Ca2+ and L-type Ca2+ channels , 2005, Brain Research.

[5]  P. Wise,et al.  Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative. , 2005, Endocrine reviews.

[6]  H. Kettenmann,et al.  Glia-neuron crosstalk in neuroninflammation, neurodegeneration and neuroprotection: Introductory comments Bianca Marchetti, Helmut Kettenmann and Wolfgang J. Streit , 2005, Brain Research Reviews.

[7]  A. Maggi,et al.  17β-Estradiol Inhibits Inflammatory Gene Expression by Controlling NF-κB Intracellular Localization , 2005, Molecular and Cellular Biology.

[8]  L. Doncarlos,et al.  Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones , 2005, Brain Research Reviews.

[9]  W. Streit.  Microglia and neuroprotection: implications for Alzheimer's disease , 2005, Brain Research Reviews.

[10]  Pier Andrea Serra,et al.  Glucocorticoid receptor–nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia–neuron interactions , 2005, Brain Research Reviews.

[11]  J. Koistinaho,et al.  Interactions between Alzheimer's disease and cerebral ischemia—focus on inflammation , 2005, Brain Research Reviews.

[12]  H. Scharfman,et al.  Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? , 2005, Trends in Neurosciences.

[13]  M. Morissette,et al.  Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ERα agonist , 2004, Neuropharmacology.

[14]  D. Dluzen,et al.  Developmental and Genetic Influences upon Gender Differences in Methamphetamine‐Induced Nigrostriatal Dopaminergic Neurotoxicity , 2004, Annals of the New York Academy of Sciences.

[15]  J Melke,et al.  Association between the estrogen receptor beta gene and age of onset of Parkinson’s disease , 2004, Psychoneuroendocrinology.

[16]  A. Maggi,et al.  Regulation of the lipopolysaccharide signal transduction pathway by 17β-estradiol in macrophage cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  P. Mcgeer,et al.  Inflammation and neurodegeneration in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[18]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[19]  C. Tirolo,et al.  Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Rossana Migheli,et al.  Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  P. Wise,et al.  Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury , 2003, The Journal of Neuroscience.

[22]  P. Wise,et al.  Estradiol Differentially Regulates c-Fos after Focal Cerebral Ischemia , 2003, The Journal of Neuroscience.

[23]  O. Lindvall,et al.  Inflammation is detrimental for neurogenesis in adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Ingram,et al.  Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice , 2003, Neuroscience.

[25]  B. Liu,et al.  Novel anti-inflammatory therapy for Parkinson's disease. , 2003, Trends in pharmacological sciences.

[26]  W. Willett,et al.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. , 2003, Archives of neurology.

[27]  M. Schiess.  Nonsteroidal anti-inflammatory drugs protect against Parkinson neurodegeneration: can an NSAID a day keep Parkinson disease away? , 2003, Archives of neurology.

[28]  P. Chambon,et al.  Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Tirolo,et al.  The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions. , 2003, Domestic animal endocrinology.

[30]  M. Horstink,et al.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system , 2003, Endocrine.

[31]  D. Ingram,et al.  Age and gender effects on microglia and astrocyte numbers in brains of mice , 2002, Brain Research.

[32]  G. Monaco,et al.  The Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induces Apoptosis in Mouse Nigrostriatal Glia , 2002, The Journal of Biological Chemistry.

[33]  Akinori Akaike,et al.  Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model , 2002, Neuropharmacology.

[34]  C. Tirolo,et al.  Exposure to a Dysfunctional Glucocorticoid Receptor from Early Embryonic Life Programs the Resistance to Experimental Autoimmune Encephalomyelitis Via Nitric Oxide-Induced Immunosuppression1 , 2002, The Journal of Immunology.

[35]  C. Tirolo,et al.  Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA , 2001, Brain Research Reviews.

[36]  P. Wise,et al.  Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies , 2001, Brain Research Reviews.

[37]  Guy C. Brown,et al.  Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.

[38]  C. Tirolo,et al.  Neuroendocrine–immune (NEI) circuitry from neuron–glial interactions to function: Focus on gender and HPA–HPG interactions on early programming of the NEI system , 2001, Immunology and cell biology.

[39]  A. Sala,et al.  Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia , 2001, The Journal of Neuroscience.

[40]  J. Chavis,et al.  Female sex steroids: effects upon microglial cell activation , 2000, Journal of Neuroimmunology.

[41]  M. Mattson,et al.  Antiinflammatory effects of estrogen on microglial activation. , 2000, Endocrinology.

[42]  K. McNaught,et al.  Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation. , 2000, Biochemical pharmacology.

[43]  T. Di Paolo,et al.  Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice , 2000, Synapse.

[44]  J. Hirrlinger,et al.  Glutathione metabolism in brain , 2000 .

[45]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[46]  A. Beaudet,et al.  Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture , 2000, Synapse.

[47]  T. Di Paolo,et al.  Ovarian steroids and raloxifene prevent MPTP‐induced dopamine depletion in mice , 2000, Neuroreport.

[48]  C. Tirolo,et al.  Gender, Neuroendocrine‐Immune Interactions and Neuron‐Glial Plasticity: Role of Luteinizing Hormone‐Releasing Hormone (LHRH) , 2000, Annals of the New York Academy of Sciences.

[49]  K. McNaught,et al.  Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures , 1999, Journal of neurochemistry.

[50]  S. Paul,et al.  Sodium Salicylate and 17β‐Estradiol Attenuate Nuclear Transcription Factor NF‐κB Translocation in Cultured Rat Astroglial Cultures Following Exposure to Amyloid Aβ1‐40 and Lipoplysaccharides , 1999 .

[51]  L. Garcia-Segura,et al.  Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. , 1999, Journal of neurobiology.

[52]  W. Koller.  Neuroprotection for parkinson's disease , 1998, Annals of neurology.

[53]  D. Ingram,et al.  Stereological analysis of astrocyte and microglia in aging mouse hippocampus , 1998, Neurobiology of Aging.

[54]  A. Ho,et al.  Induction of Interleukin-1 Associated with Compensatory Dopaminergic Sprouting in the Denervated Striatum of Young Mice: Model of Aging and Neurodegenerative Disease , 1998 .

[55]  J. O'Callaghan,et al.  The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity , 1998, Annals of the New York Academy of Sciences.

[56]  B. Marchetti,et al.  Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network. , 1997, Frontiers in bioscience : a journal and virtual library.

[57]  M. C. Morale,et al.  Disruption of hypothalamic-pituitary-adrenocortical system in transgenic mice expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: effects on T cell trafficking and T cell responsiveness during postnatal development. , 1995, Endocrinology.

[58]  T. Takeshima,et al.  Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  N. Barden,et al.  Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene , 1992, Nature.

[60]  M. C. Morale,et al.  The thymus gland as a major target for the central nervous system and the neuroendocrine system: Neuroendocrine modulation of thymic β2-Adrenergic receptor distribution as revealed by in vitro autoradiography , 1990, Molecular and Cellular Neuroscience.

[61]  R. Sandyk.  Estrogens and the pathophysiology of Parkinson's disease. , 1989, The International journal of neuroscience.

[62]  C. Behl.  Oxidative stress in Alzheimer's disease: implications for prevention and therapy. , 2005, Sub-cellular biochemistry.

[63]  C. Léránth,et al.  The 17α and 17β Isomers of Estradiol Both Induce Rapid Spine Synapse Formation in the CA1 Hippocampal Subfield of Ovariectomized Female Rats , 2005 .

[64]  D. Dorsa,et al.  Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. , 2003, Endocrinology.

[65]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[66]  A. Schapira,et al.  Genetic and environmental factors in the cause of Parkinson's disease , 2003, Annals of neurology.

[67]  Y. Agid,et al.  Neuroprotection for Parkinson's disease: Prospects and promises , 2003, Annals of neurology.

[68]  S. Hunot,et al.  Neuroinflammatory processes in Parkinson's disease , 2003, Annals of neurology.

[69]  B. McEwen,et al.  Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. , 2001, Annual review of pharmacology and toxicology.

[70]  L. Garcia-Segura,et al.  Astroglia play a key role in the neuroprotective actions of estrogen. , 2001, Progress in brain research.

[71]  M. C. Morale,et al.  Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormone milieu and correlation with sexual dimorphism of immune response , 1994 .

[72]  James H. Clark,et al.  Female Sex Steroids , 1979 .